New York-based Immunai, a biotech that uses single-cell genomics and machine learning to discover and improve development of ...

Shares of China’s Hansoh Pharmaceutical edged up 2% to HK$36.50 as it announced a license agreement with Roche for HS-20110, ...

Chinese biotech Kelun-Biotech (HKEX: 6990) has gained approval from the National Medical Products Administration for ...

US pharma major Eli Lilly has announced results from the primary overall survival (OS) analysis of the Phase III monarchE ...

Anglo-Swedish pharma major AstraZeneca (LSE: AZN) has presented new data showing the impact of its PD-L1 inhibitor Imfinzi ...

German pharma group Merck (MRK: DE) has become the third company to strike a cost-cutting agreement with the Trump ...

The European Medicine Agency’s (EMA) human medicines committee (CHMP) recommended two novel medicines for approval at its ...

US hematology specialist Disc Medicine surged 19.7% in after-hours trading Thursday after the company announced it received a ...

USA-based clinical-stage dermatology start-up Veradermics has announced the completion of an oversubscribed $150 million ...

The UK NHS Business Services Authority (NHSBSA) has released its latest General Services report. The report shows the ...